TEC
BHC icon

Tiger Eye Capital’s Bausch Health BHC Stock Holding History

Tiger Eye Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-290,768
Closed -$64.6M – 36
2015
Q2 		$64.6M Buy
290,768
+161,913
+126% +$35.9M 4.75% 2
2015
Q1 		$25.6M Buy
128,855
+47,755
+59% +$8.47M 2.03% 26
2014
Q4 		$11.6M Buy
+81,100
New +$10.9M 0.92% 38
2014
Q3 		– Sell
-160,176
Closed -$20.2M – 49
2014
Q2 		$20.2M Sell
160,176
-93,324
-37% -$11.9M 2.12% 20
2014
Q1 		$33.4M Sell
253,500
-26,500
-9% -$3.62M 4.96% 4
2013
Q4 		$32.9M Buy
+280,000
New +$30.7M 4.11% 5

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Tiger Eye Capital's BHC Position: Q3 2015 in Review

Tiger Eye Capital sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 290,768 shares — an estimated $64.6M sold.

Tiger Eye Capital first reported a position in BHC in Q4 2013 and held it in 6 quarters. The position peaked at $64.6M in Q2 2015. 547 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • Tiger Eye Capital reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • Tiger Eye Capital sold 290,768 Bausch Health shares in Q3 2015, an estimated $64.6M.
  • Tiger Eye Capital first reported a position in Bausch Health in Q4 2013 and held it in 6 quarters.
  • Tiger Eye Capital's Bausch Health position peaked at $64.6M in Q2 2015.
  • 547 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Tiger Eye Capital's 13F filing for Q3 2015, filed 10 Nov 2015.